Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 2/20 | 0.36 |
| ▸ | ACHE | P22303 | 2/20 | 0.36 |
| ▸ | NAAA | Q02083 | 4/20 | 0.36 |
| ▸ | GJB2 | P29033 | 1/20 | 0.33 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.33 |
| ▸ | HTR1A | P08908 | 1/20 | 0.32 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14958146 | 1.00 | BCHE (0.36) | BCHEACHENAAAGJB2PDE4D | |
| SCHEMBL17644796 | 1.00 | BCHE (0.36) | BCHEACHENAAAGJB2PDE4D | |
| SCHEMBL14957939 | 0.82 | BCHE (0.40) | BCHEACHEGJB2PDE4DHTR1A | |
| SCHEMBL13424415 | 0.75 | PDE4D (0.38) | BCHEACHEPDE4D | |
| SCHEMBL13424413 | 0.75 | BCHE (0.36) | BCHEACHEPDE4D | |
| SCHEMBL12393051 | 0.74 | TAAR1 (0.38) | BCHEACHEPDE4DTAAR1 | |
| SCHEMBL14957605 | 0.73 | EPHX2 (0.32) | BCHEACHE | |
| SCHEMBL783646 | 0.71 | TAAR1 (0.37) | BCHEACHEPDE4DTAAR1 | |
| SCHEMBL783701 | 0.71 | TAAR1 (0.40) | BCHEACHEGJB2PDE4DTAAR1 | |
| SCHEMBL13424419 | 0.71 | BCHE (0.38) | BCHEACHEPDE4D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9120781-B2 | Selective glycosidase inhibitors and uses thereof | SIMON FRASER UNIVERSITY (CA) | 2015-09-01 | — | — | US | disclosed |
| US-20130131044-A1 | SELECTIVE GLYCOSIDASE INHIBITORS AND USES THEREOF | SIMON FRASER UNIVERSITY (CA) | 2013-05-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130131044-A1 | SELECTIVE GLYCOSIDASE INHIBITORS AND USES THEREOF | ENGASE, OGA, GALE | BCHE 632/4885ACHE 1227/4885NAAA 280/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.